Search

  • HOME
  • Search
Original Articles
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bron
Young Whan Kim, Young Soo Shim, Won Dong Kim, Tae Sun Shim, Hong Mo Kang, Byoung Whui Choi, Jae Yeol Kim, O Jung Kwon, Hojoong Kim, Ju Ock Kim, Ki Suck Jung, In Gyou Hyeon, Eun Kyung Mo, Seung Joon Lee, Gui Hyun Nam, Kye Young Lee, Jae Seuk Park
Tuberc Respir Dis. 2003;55(1):69-87.   Published online July 1, 2003
PDFPDF    
Changes of Sputum Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinase-1 by Antibiotic Treatment in Acute Exacerbation of Chronic Bronchitis.
Hyoung Kyu Yoon, Joong Hyun Ahn, Chi Hong Kim, Soon Seog Kwon, Young Kyoon Kim, Kwan Hyung Kim, Hwa Sik Moon, Sung Hak Park, Jeong Sup Song
Tuberc Respir Dis. 2002;53(4):420-430.   Published online October 1, 2002
PDFPDF    
A Multicenter, Randomized, Open, Comparative Study for the Efficacy and Safety of Oral Moxifloxacin 400 mg Once a Day and Clarithromycin 500 mg Twice Daily in Korean Patients with Acute Exacerbations of Chronic Bronchitis.
Seung Joon Kim, Seok Chan Kim, Sook Young Lee, Hyeong Kyu Yoon, Tae Yon Kim, Young Kyoon Kim, Jeong Sup Song, Sung Hak Park, Ho Joong Kim, Man Pyo Chung, Gee Young Suh, O Jung Kwon, Shin Hyung Lee, Kyung Ho Kang, Eh Hyung Lee, Sung Chul Hwang, Myung Ho Ha
Tuberc Respir Dis. 2000;49(6):740-751.   Published online December 1, 2000
PDFPDF    

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184



ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next